Effects of mesoridazine: A Synthesis of Findings from 27 Studies
- Home
- Effects of mesoridazine
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of mesoridazine: A Synthesis of Findings from 27 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major Research Findings
Mesoridazine is a phenothiazine antipsychotic drug that has been used to treat mental illness. 26 reports on the effectiveness of mesoridazine in the treatment of schizophrenia and other psychiatric disorders. 19 studies the interaction of mesoridazine and other phenothiazines with carbamazepine, finding that carbamazepine accelerates the metabolism of these neuroleptics, except for perazine. 7 suggests that mesoridazine can prolong the QT interval of the heart, which can increase the risk of arrhythmias and sudden death. 11 shows that mesoridazine can act as a partial agonist at dopamine receptors. 1 indicates that mesoridazine can stimulate the rat organic cation transporter 2, but not its human ortholog. 3 suggests that mesoridazine can photodegrade, producing transformation products that may persist in the environment and have potential ecotoxicity.
Benefits and Risks
Benefits Summary
Mesoridazine has been shown to be effective in treating mental illnesses such as schizophrenia. 26 highlights its effectiveness compared to other antipsychotics. Mesoridazine may have fewer side effects, such as movement disorders, compared to other antipsychotics. 22 shows that mesoridazine can enhance latent inhibition, a cognitive process involved in focusing attention. Mesoridazine may have analgesic properties. 5 suggests this effect.
Risks Summary
Mesoridazine can affect the heart's electrical activity and prolong the QT interval. 7 This can increase the risk of arrhythmias and sudden death. Mesoridazine may be more likely to prolong the QT interval in patients with low potassium levels. 8 explains this risk. Mesoridazine can inhibit gap junctions, which are important for cell-to-cell communication. 9 reports on this inhibition. Mesoridazine may alter serotonin receptor activity. 16 This could lead to mental health problems. Mesoridazine can act as an inverse agonist at serotonin 2C receptors. 17 Mesoridazine can photodegrade, producing transformation products that may persist in the environment and have potential ecotoxicity. 3
Comparison between Studies
Similarities
Mesoridazine has been shown to be effective in treating mental illness. 26 22 Mesoridazine can affect dopamine receptor activity. 11 Mesoridazine can affect the heart's electrical activity. 7 8
Differences
Mesoridazine may affect serotonin receptor activity. 16 However, it can also act as an inverse agonist at serotonin 2C receptors. 17 1 suggests that mesoridazine can stimulate the rat organic cation transporter 2. 3 indicates that mesoridazine can photodegrade.
Consistency and Discrepancies
Mesoridazine is an effective treatment for mental illness. 26 However, it can prolong the QT interval of the heart. 7 8 The mechanism of action of mesoridazine on serotonin receptor activity remains unclear. 16 17 Mesoridazine can photodegrade and generate transformation products that may persist in the environment. 3
Real-World Application Considerations
While mesoridazine can be an effective treatment for mental illness, it is important to consider the potential risks associated with its use. 26 The drug can prolong the QT interval, leading to an increased risk of arrhythmias and sudden death. 7 8 Monitoring the heart's health is crucial while taking mesoridazine. 3 highlights the environmental concerns with mesoridazine and its potential to persist in the environment. It's essential to minimize environmental impact.
Limitations of Current Research
More research is needed to fully understand the effects of mesoridazine. 26 Further studies should focus on the drug's effects on the heart and its environmental impact. 7 3 Larger studies with more participants are also necessary for a more comprehensive understanding of mesoridazine's effects.
Future Research Directions
Further research is required to better understand mesoridazine's effects, especially its effects on the heart. 7 8 Research focusing on the environmental impact of mesoridazine is also needed. 3 Additionally, more research on mesoridazine's side effects and its interaction with other medications is necessary.
Conclusion
Mesoridazine can be an effective treatment for mental illness, but it is important to consider the potential risks associated with its use. 26 The drug can affect the heart's electrical activity and prolong the QT interval, potentially increasing the risk of arrhythmias and sudden death. 7 8 The mechanism by which mesoridazine affects serotonin receptor activity is not fully understood. 16 17 3 Additionally, the drug can photodegrade and generate transformation products that may persist in the environment. Monitoring heart health is crucial during mesoridazine treatment. It is essential to minimize the environmental impact of the drug. Further research is necessary to gain a complete understanding of the effects of mesoridazine.
Benefit Keywords
Risk Keywords
Article Type
Author: HyungSungwoo, PyeonWonji, ParkJi Eun, SongYoo-Kyung, ChungSuk-Jae
Language : English
Author: WildeMarcelo L, MenzJakob, LederChristoph, KümmererKlaus
Language : English
Author: SeredeninaTamara, ChirianoGianpaolo, FilippovaAleksandra, NayerniaZeynab, MahioutZahia, Fioraso-CartierLaetitia, PlastreOlivier, ScapozzaLeonardo, KrauseKarl-Heinz, JaquetVincent
Language : English
Author: ImSo Hee, ParkMyoung Joo, SeoHyewon, ChoiSung Heum, KimSang Kyum, AhnSung-Hoon
Language : English
Author: ChenYu-Wen, ChuChin-Chen, ChuKoung-Shing, ShiehJa-Ping, ChienChih-Chiang, WangJhi-Joung, KaoCheng-Hsing
Language : English
Author: AparasuRajender R, JanoElda, JohnsonMichael L, ChenHua
Language : English
Author: ThanacoodyR H K, DalyA K, ReillyJ G, FerrierI N, ThomasS H L
Language : English
Author: LimberisJames T, SuZhi, CoxBryan F, GintantGary A, MartinRuth L
Language : English
Effect of thioridazine on gap junction intercellular communication in connexin 43-expressing cells.
Author: MatesicD F, AbifadelD N, GarciaE L, JannM W
Language : English
Author: WójcikowskiJacek, MaurelPatrick, DanielWładysława A
Language : English
Author: BursteinE S, MaJ, WongS, GaoY, PhamE, KnappA E, NashN R, OlssonR, DavisR E, HacksellU, WeinerD M, BrannM R
Language : English
Author: GlassmanAlexander H
Language : English
Author: SuZhi, MartinRuth, CoxBryan F, GintantGary
Language : English
Author: LLerenaAdrián, BereczRoland, de la RubiaAlfredo, DoradoPedro
Language : English
Author: LLerenaA, BereczR, de la RubiaA, Fernández-SalgueroP, DoradoP
Language : English
Author: RauserL, SavageJ E, MeltzerH Y, RothB L
Language : English
Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors.
Author: Herrick-DavisK, GrindeE, TeitlerM
Language : English
Author: DanielW A, SyrekM, HaduchA, WójcikowskiJ
Language : English
Author: DanielW A, SyrekM, HaduchA, WójcikowskiJ
Language : English
Clonidine does not potentiate the antipsychotic effects of neuroleptics in chronically ill patients.
Author: HedgesS, El-MallakhR S, IssaF, ElkashefA, BigelowL B, WyattR J
Language : English
Author: RothB L, TandraS, BurgessL H, SibleyD R, MeltzerH Y
Language : English
Author: DunnL A, AtwaterG E, KiltsC D
Language : English
Author: NiemannJ T, StapczynskiJ S, RothsteinR J, LaksM M
Language : English
Author: BreuningS E, DavidsonN A
Language : English
Author: SturgeonR D, FesslerR G, LondonS F, MeltzerH Y
Language : English
Author: GershonS, SakalisG, BowersP A
Language : English
Author: BylundD B
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.